NDC 54092-701 – Vpriv
Velaglucerase Alfa 2.5 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC54092-701
Product details
- Brand name
- Vpriv
- Generic name
- Velaglucerase alfa
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA022575
- Marketed since
- February 26, 2010
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Active ingredients
- Velaglucerase Alfa 2.5 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 54092-701-04 | 1 VIAL, GLASS in 1 BOX (54092-701-04) / 4 mL in 1 VIAL, GLASS | Feb 26, 2010 |
Recalls mentioning this NDC
- D-1251-2014 Apr 30, 2014 · Class I
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.